洋地黄毒苷诱导小细胞肺癌NCI-H446细胞增殖和凋亡的影响

应用四甲基偶氮唑盐(MTT)法检测洋地黄毒苷对NCI-H446细胞增殖的抑制效果;用AO-EB染色、DNA凝胶电泳分析以及AnnexinⅤ检测法检测细胞凋亡;用碘化丙啶(PI)染色测定其周期变化,利用激光共聚焦显微镜观察细胞内活性氧(ROS)和钙离子(Ca2+)的变化.结果显示洋地黄毒苷明显抑制NCI-H446细胞增殖,AO-EB染色、DNA电泳及AnnexinV检测法显示细胞有明显的凋亡现象,PI染色显示处于S期的细胞增多,激光共聚焦显微镜观察表明细胞内活性氧和钙离子浓度均升高.表明洋地黄毒苷能明显抑制NCI-H446细胞增殖,且细胞被阻滞在S期.细胞内活性氧和钙离子浓度的增加可能与其诱导细胞凋亡有关.     

长非编码RNA LINC00941在结直肠癌中的表达及对细胞增殖的影响研究

为了研究与细胞分化相关的长非编码RNA(long non-coding RNA, lncRNA) LINC00941在肿瘤发生发展中的作用,通过实时荧光定量PCR技术检测LINC00941在6种不同类型的人类癌细胞和正常胚胎肾细胞HEK-293细胞中的表达水平,结果表明,LINC00941在结直肠癌细胞HCT116和HCT116 p53-/-、肺癌细胞A549和NCI-H1299、黑素瘤细胞Stilling中均有较高的表达水平,在结直肠癌细胞中表达水平最高. 以结直肠癌患者肿瘤组织和癌旁正常组织为材料,实时荧光定量PCR检测LINC00941的表达水平发现,肿瘤组织中LINC00941 RNA的表达水平显著高于癌旁组织. 通过shRNA(short hairpin RNA)干扰技术降低HCT116细胞中的LINC00941 RNA水平,导致细胞增殖速度下降,说明LINC00941与结直肠癌的发生发展相关.     

干扰长链非编码RNA NEAT1上调miR-126抑制胃癌细胞的生长、间质转换及裸鼠肿瘤形成

目的 研究干扰长链非编码RNA核富集的转录物1(NEAT1)上调miR-126抑制胃癌细胞的生长,间质转换及裸鼠肿瘤形成的影响.方法 通过RT-PCR分析NEAT1在胃癌MGC-803、SGC-7901细胞和正常胃上皮GES-1细胞中的表达,并检测sh-NEAT1的沉默效率.NEAT1沉默后,EDU染色分析肿瘤细胞的增...     

栓塞化疗后原发性肝癌的病理变化研究

探讨肝癌肝动脉栓塞化疗后肿瘤的病理及某些分子生物学的变化。方法：从１９９２年１月到１９９７年１２月,结合临床对手术切除的原发性肝癌术前曾接受肝动脉栓塞化疗的１１７例标本作大体病理、镜下病理、免疫组化方法的肿瘤增殖细胞核抗原（ＰＣＮＡ）,ｐ５３蛋白及抑癌基因ｐ５３ＰＣＲ技术的检测。结果：肉眼见坏死组织约占肿瘤体积不到５０％的有３２例,坏死占５０％～９０％的有５４例,９０％以上而有未完全坏死的有１８例,１００％的有１３例。镜下仍见有肿瘤细胞的有１１１例,全部为坏死组织而未见肿瘤细胞的有６例。肿瘤增殖细胞核抗原（ＰＣＮＡ）高指数的有７２例（６４９％）,ｐ５３表达强阳性的有８５例（７６６％）。结论：本组资料表明,肝动脉栓塞化疗能使大部分肿瘤细胞坏死,但仅有极少部分全部坏死,而未坏死的肿瘤细胞增殖活跃     

Identity of the proliferating cell nuclear antigen and cyclin

Studies of growth regulation and cellular transformation will be assisted by the identification of proteins that are preferentially synthesized in dividing cells. The 'proliferating cell nuclear antigen' ( PCNA ), distinguished by its apparent association with cell division, is defined by reaction with an antibody found in the autoimmune disease systemic lupus erythematosus (SLE). This antibody reacts with proliferating cells including tumour cells but gives weak or undetectable immunofluorescence with resting cells of normal tissues. Peripheral blood lymphocytes are devoid of PCNA until activated by mitogen in vitro. In synchronized cultures its level and distribution fluctuate through the cell cycle, with a striking accumulation in the nucleolus late in the G1 phase and early in the S phase. Many of these properties are shared by ' cyclin '. This nuclear protein, identified by its position in a two-dimensional separation of cell proteins, is also transformation-sensitive and is preferentially synthesized in the S phase. We establish here that PCNA and cyclin are identical, and show that PCNA is an acidic nuclear protein of apparent molecular weight 35,000.     

新型多酸化合物对人乳腺癌细胞增殖的抑制作用

采用MTT法、形态学方法和Western blot方法,检测了3种新型多酸化合物[SbW9、（SbW9）2-（SnR）4、（SbW9）2-（SnR-CH3）4]对人乳腺癌MCF7和MDA-MB-231细胞生长抑制作用,细胞形态学变化及细胞PCNA蛋白表达变化,并探讨该3种化合物抑癌的机制.实验结果表明：3种化合物对人乳腺癌细胞MCF7和MDA-MB-231的生长均具有明显的抑制作用（P〈0.01）,细胞形态发生明显变化,细胞皱缩并且增殖速度明显减慢;其中,（SbW9）2-（SnR）4可使MCF7细胞PCNA蛋白表达下降（P〈0.05）,且呈浓度剂量依赖性.说明该3种新型多酸化合物均具有抗肿瘤活性,其活性部位可能是以{SbW9}为基本建筑单元的聚阴离子,作用机制可能与其抑制细胞DNA的合成有关.     

PPARγ罗格列酮对HT-29的生长抑制作用

PPARγ配体在抗肿瘤中发挥着重要的作用,这些配体具有抗肿瘤、诱导分化和抗血管生成等效果.目的主要是评估PPARγ激动剂罗格列酮对结肠癌细胞株HT-29生长的抑制作用.结果显示,罗格列酮可以有效地抑制体外培养的结肠癌细胞株HT-29的生长及克隆形成,并能抑制HT-29裸鼠移植瘤的生长.与此同时,罗格列酮能够升高PPARγ, p- PPARγ的表达水平.以上结果初步证明罗格列酮在体内外均可抑制结肠癌细胞株HT-29的成长,提示罗格列酮有可能发展成为治疗结肠癌的有效药物.     

加热对血管平滑肌细胞的影响实验研究

 为支架磁感应热疗预防和治疗PTCA术后血管再狭窄提供基础研究数据,对临床常用的316L型不锈钢冠脉支架进行磁感应诱导升温,探讨加热对兔血管平滑肌细胞（VSMCs）的增殖、迁移、凋亡及周期的影响。将平滑肌细胞置于恒温水浴槽中,待其达到预定温度（43、47℃）后持续10min,观察细胞形态变化,采用MTT法检测加热对血管平滑肌细胞增殖活性的影响,流式细胞术检测VSMC细胞周期和细胞凋亡,划痕实验检测加热对细胞迁移能力的影响,免疫细胞化学法检测不同温度作用后血管平滑肌细胞中增殖细胞核抗原（PCNA）的表达。结果发现,支架在交变磁场下可以升温至热疗所需温度,加热后细胞增殖受到了显著抑制,43℃组细胞存活率为（83.23±2.87）%,47℃组细胞存活率仅为（37.58±0.78）%。细胞的凋亡率显著增加,47℃组细胞凋亡率为（87.37±2.95）%,与对照组相比具有极显著差异,而43℃组的凋亡率为（6.00±0.26）%,与对照组相比无统计学差异。细胞周期也受到抑制,被阻滞在S期。加热后随着时间的推移,47℃组细胞的迁移能力受到显著抑制,而加热对43℃组细胞的迁移能力无显著影响。免疫细胞化学检测显示,随着温度的升高,PCNA的表达受到明显抑制。研究表明,临床常用冠脉支架在交变磁场下升温可行。加热显著抑制了细胞的增殖并促进了细胞凋亡,使细胞周期阻滞在S期,且抑制了细胞的迁移。加热能显著抑制细胞PCNA的表达,这些可能是加热抑制细胞增殖和迁移、促进凋亡的机制之一。     

HMBA对人成骨肉瘤MG-63细胞增殖和相关基因表达的影响

研究了环六亚甲基双乙酰胺对人成骨肉瘤MG-63细胞的增殖和相关基因表达的影响.实验结果表明HMBA可明显抑制MG-63细胞的增殖,细胞生长抑制率达50.69%,分裂指数抑制率达58.8%,增殖细胞核抗原的表达降低,细胞周期被阻滞在G0/G1期.免疫细胞化学染色结果显示,经HMBA处理之后,与增殖分化调控有关的癌基因c-myc、c-fos、c-erbB-2、mtp53的表达降低、抑癌基因p21WAF1/CIP1、p16、rb的表达升高.研究结果表明,HMBA能够有效抑制人成骨肉瘤MG-63细胞的增殖活动,其对细胞增殖的抑制作用与HMBA下调c-myc、c-fos、c-erbB-2、mtp53等癌基因以及上调p21WAF1/CIP1、p16、rb等抑癌基因的表达,从而调控细胞周期有重要关系.     

hPNAS-4腺病毒载体的构建及其体外抗肿瘤作用

[摘要] 目的：构建携带人的凋亡相关新基因PNAS-4(hPNAS-4)的重组腺病毒,并观察其感染人肺癌A549细胞所引起的hPNAS-4过表达对体外肿瘤细胞凋亡的影响。方法：用RT-PCR从293A细胞中克隆hPNAS-4编码区cDNA,将其酶切后连接至pENTR11载体上,再通过pENTR11与腺病毒骨架载体pAd/CMV/V5-DEST之间的同源重组作用将hPNAS-4基因片段重组至pAd/CMV/V5-DEST上,最后经293细胞的包装扩增后得到携带hPNAS-4基因的重组腺病毒;将重组腺病毒体外感染人肺癌A549细胞;用RT-PCR检测感染细胞中hPNAS-4的过表达情况;通过MTT、流式细胞术及DNA Ladder分别检测感染细胞的增殖与凋亡情况。结果：从293A细胞中中克隆到hPNAS-4全长cDNA并成功构建腺病毒表达载体Ad-hPNAS-4,经测定其滴度为：2.4×108 pfu/ml,感染人肺癌A549细胞后：经RT-PCR测得其mRNA表达明显上调,MTT检测结果为细胞增殖受到明显抑制,流式细胞术测得细胞凋亡率明显升高,琼脂糖凝胶电泳显示其基因组DNA有明显的梯状条带（DNA ladder）;结论：hPNAS-4腺病毒载体感染人肺癌A549细胞后,发现hPNAS-4过表达对肿瘤细胞的生长有明显的抑制和诱导凋亡作用,为今后研究其分子机制以及hPNAS-4腺病毒载体应用于肿瘤动物实验和肿瘤基因治疗提供实验资料。     

Suppression of murine breast cancer metastasis by selective inhibition of CXCR4 by synthetic polypeptide derived from viral macrophage inflammatory protein II

Stromal cell-derived factor-1 and its receptor CXC chemokine receptor-4 (CXCR4) have been implicated in breast cancer metastasis. A significant association between HER2 and CXCR4 expression has been observed in human breast tumor tissues, and overexpression of CXCR4 is essential for HER2-mediated tumor metastasis. Moreover, CXCR4 expression is low in normal breast tissues and high in malignant tumors, suggesting that a blockade of CXCR4 may limit tumor metastasis. The present study investigated the action of a synthetic antagonist 21-mer peptide derived from viral macrophage inflammatory protein II against CXCR4 (NT21MP) in inhibiting metastasis in vitro and in vivo. The results showed that chemotaxis of SKBR3 cells toward SDF-1α was reduced by NT21MP in a dose-dependent manner (P < 0.05). NT21MP inhibited tumor growth at 500 μg/kg and in combination with Herceptin, the anti-HER2 antibody. The in vivo metastatic assay showed that NT21MP significantly inhibited pulmonary metastasis, and the number of metastatic tumor nodes on the surface of the lung was greatly decreased. Compared with the saline-treated control group, PCNA expression was dose-dependently decreased by NT21MP, the percentage of apoptotic cells was increased, and CXCR4 mRNA and protein expression were downregulated. In conclusion, NT21MP inhibits cellular prolifer-ation, promotes apoptosis by downregulating CXCR4 expression, and suppresses the progression of primary and metastatic tumors. CXCR4 may be a useful therapeutic target for breast cancer, and NT21MP may serve as a potential target drug for the treatment of breast cancer metastasis.     

FEZF1在结直肠癌组织和癌旁正常组织中的表达及临床意义

本文旨在探究FEZF1蛋白在结直肠癌组织和癌旁组织中的表达和其临床意义.通过免疫组化实验和Western Blot实验以及细胞实验,发现FEZF1在结直肠癌组织中低表达,并且其表达与肿瘤淋巴结转移(tumor node metastasis,TNM)分期具有显著相关性,在FEZF1低表达时,RKO细胞增殖和迁移能力提高,FEZF1高表达时RKO细胞增殖能力减弱.本研究证明了FEZF1是结直肠癌中的一个低表达蛋白,其表达与结直肠组织癌变的发生、发展相关,并且FEZF1会抑制结直肠癌细胞的增殖和迁移.     

重组腺病毒Canstatin对人肝癌HepG2细胞增殖影响的研究

为研究重组腺病毒Canstatin感染人肝癌HepG2细胞及细胞转染后Canstatin在HepG2细胞中的表达,探讨Canstatin基因对人肝癌HepG2细胞生长增殖的影响。采用不同感染复数(MOI=10、40、80)的腺病毒Ad-Canstatin-GFP感染HepG2细胞,倒置荧光显微镜下观察细胞形态,流式检测感染效率,Real-Time PCR和Western blot法检测HepG2细胞中Canstatin mRNA和蛋白表达。CCK-8法检测细胞增殖能力的变化,Western blot法检测细胞中PCNA蛋白的表达。结果显示MOI为40时,72 h感染率可达到98.9%,HepG2细胞中Canstatin mRNA和蛋白表达均高于对照组和空载体组(P0.05)。HepG2细胞感染Ad-Canstatin腺病毒后生长增殖受到抑制(P0.05),且PCNA的表达低于对照组(P0.05)。由此可知,Canstatin抑制人肝癌HepG2细胞的生长增殖有作用可能与影响PCNA的表达有关。     

Metformin targets liver tumor-initiating cells through the PI3K/Akt/mTOR survival pathway

Liver tumor-initiating cells （T-ICs） are thought to be inherently resistant to the cytotoxic effects of chemo- therapy, and can self-renewal and maintain tumor-initiating potential. Therefore, effective anticancer research strategies should target the unique properties of T-ICs. In this study, we found that metformin, a first-line drug of choice for the treatment of type 2 diabetes, inhibited liver T-ICs both in vivo and in vitro. Metformin inhibited the formation of hepato- spheres and epithelial-specific antigen-positive （ESA, CD133＋） cell colonies by hepatocellular carcinoma （HCC） cell lines. Metformin also downregulated the expression of several T-IC-related genes which are involved in the signal- ing pathways, governing the self-renewal, proliferation and differentiation of T-ICs. Furthermore, the targeting of liver T-ICs by metformin was PI-3-kinase-Akt-mTOR （PI3K/Akt/ mTOR）-pathway dependent. The PI3K/Akt/mTOR inhibitorLY294002 and rapamycin abolished the inhibitory effect of metformin on CD133＋ cells, and the PI3K/Akt/mTOR stimulator EGF promoted the inhibitory effect of mefformin on CD 133＋ cells. Metformin also dramatically decreased the tumor volume and number of CD133 expressing tumor cells in a xenograft mouse model. Mefformin exerted a synergistic effect with cisplatin to target both T-ICs and non-T-ICs, and resulted in the smallest tumor volume and lowest number of CD133 expressing tumor cells. This study indicates that the antidiabetic drug metformin could potentially be used in combination therapy with chemotherapeutic agents to improve the treatment of liver cancer.     

Molecular structure and biological function of proliferating cell nuclear antigen

Proliferating cell nuclear antigen (PCNA) is the core component of replication complex in eukaryote. As a processive factor of DNA polymerase delta, PCNA coordinates the replication process by interacting with various replication proteins. PCNA appears to play an essential role in many cell events, such as DNA damage repair, cell cycle regulation, and apoptosis, through the coordination or organization of different partners. PCNA is an essential factor in cell proliferation, and has clinical significance in tumor research. In this article we review the functional structure of PCNA, which acts as a function switch in different cell events.     

Molecular structure and biological function of proliferating cell nuclear antigen

Proliferating cell nuclear antigen (PCNA) is the core component of replication complex in eukaryote. As a processive factor of DNA polymerase delta, PCNA coordinates the replication process by interacting with various replication proteins. PCNA appears to play an essential role in many cell events, such as DNA damage repair, cell cycle regulation, and apoptosis, through the coordination or organization of different partners. PCNA is an essential factor in cell proliferation, and has clinical significance in tumor research. In this article we review the functional structure of PCNA, which acts as a function switch in different cell events.     

Ginsenosides stimulated the proliferation of mouse spermatogonia involving activation of protein kinase C

The effect of ginsenosides on proliferation of type A spermatogonia was investigated in 7-day-old mice. Spermatogonia were characterized by c-kit expression and cell proliferation was assessed by immunocytochemical demonstration of proliferating cell nuclear antigen (PCNA). After 72-h culture, Sertoli cells formed a confluent monolayer to which numerous spermatogonial colonies attached. Spermatogonia were positive for c-kit staining and showed high proliferating activity by PCNA expression. Ginsenosides (1.0~10 μg/ml) significantly stimulated proliferation of spermatogonia. Activation of protein kinase C (PKC) elicited proliferation of spermatogonia at 10⁻⁸ to 10⁻⁷ mol/L and the PKC inhibitor H₇ inhibited this effect. Likewise, ginsenosides-stimulated spermatogonial proliferation was suppressed by combined treatment of H₇. These results indicate that the proliferating effect of ginsenosides on mouse type A spermatogonia might be mediated by a mechanism involving the PKC signal transduction pathway.     

ERK信号转导通路在PDGF诱导的人动脉平滑肌细胞增殖中的作用

了解ERK信号转导通路在PDGF诱导的人动脉平滑肌细胞增殖中的作用.原代培养人脐动脉平滑肌细胞（hUASMC）,取生长正常的细胞分4组：对照组,PDGF（platelet derived growth factor）组,ERK阻断剂组和PDGF＋ERK阻断剂组.继续培养24h后,用免疫细胞化学技术测细胞核内核增殖抗原（PCNA）的表达;用MTT法测细胞的增殖活性.结果显示：1）与对照组相比,PDGF组细胞内PCNA 的表达明显增强,MTT法测得A值也升高（P〈0.01）.2）ERK阻断剂可完全抑制PDGF诱导的PCNA 的表达增多和A值的升高.结论：ERK信号转导通路参与了PDGF诱导的人动脉平滑肌细胞的增殖.     

重组人三叶因子3对细胞的增殖及迁移的影响

将重组人三叶因子3(Trefoil factor 3, TFF3)作用于人结肠肿瘤细胞,研究重组蛋白对细胞增殖的影响,结果发现该蛋白在较低的浓度(10～50 mg/L)下对细胞的增殖基本没有影响,在100～200 mg/L浓度下该蛋白对细胞仅有微弱的刺激作用,提高浓度对细胞增殖作用没有改变。同时研究了TFF3对损伤的单层结肠肿瘤细胞迁移的影响,发现TFF3对细胞有明显的促进迁移作用。     

LncRNA SIL沉默促进A549细胞增殖和迁移

研究了lncRNA SIL与肺纤维化中肺泡上皮细胞的增殖和迁移之间的关系.设计小干扰RNA沉默内源性lncRNA SIL的表达,通过RT-PCR、MTT、Western blot、细胞损伤修复实验及Transwell实验研究沉默后细胞的增殖和迁移变化.MTT结果显示:沉默lncRNA SIL后细胞的增殖能力与对照组相比...